1.上海市宝山区中西医结合医院/上海中医药大学附属宝山医院 上海 201999
2.上海市嘉定区华亭镇社区卫生服务中心
3.上海中医药大学研究生院
石岭,男,硕士,主治医师
#罗梅宏,女,博士,主任医师,博士生导师,主要研究方向:血液病的中医药基础与临床研究,E-mail:lmh021009@163.com
纸质出版日期:2024-09-30,
网络出版日期:2024-08-20,
收稿日期:2024-05-15,
移动端阅览
石岭, 季玉婷, 郑秦, 等. 基于运脾法拆方研究异功散治疗慢性病贫血的机制[J]. 北京中医药大学学报, 2024,47(9):1247-1255.
SHI Ling, JI Yuting, ZHENG Qin, et al. Study on the mechanism of
石岭, 季玉婷, 郑秦, 等. 基于运脾法拆方研究异功散治疗慢性病贫血的机制[J]. 北京中医药大学学报, 2024,47(9):1247-1255. DOI: 10.3969/j.issn.1006-2157.2024.09.009.
SHI Ling, JI Yuting, ZHENG Qin, et al. Study on the mechanism of
目的
2
观察陈皮在异功散改善慢性病贫血铁代谢、促进红细胞生成中的作用。
方法
2
将异功散进行拆方分为陈皮单药和陈皮缺味方,采用2×2析因设计方法,将32只酵母糖诱导的全身炎症反应模型小鼠按随机数字表法分为模型组、陈皮组、陈皮缺味方组和异功散全方组,每组8只。陈皮组(3.083 g/kg)、陈皮缺味方组(12.33 g/kg)和异功散全方组(15.413 g/kg)小鼠分别灌胃相应药物,模型组小鼠灌胃等量生理盐水,连续7 d。给药结束后,记录各组小鼠体质量,采用全自动细胞计数仪检测各组小鼠血红蛋白含量,比色法检测血清铁含量,酶联免疫吸附测定(ELISA)法检测血清铁蛋白含量,计算脾指数,Luminex法检测肝脏组织炎症因子白细胞介素-1β(IL-1β)、白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)、γ干扰素(IFN-γ)、白细胞介素-4(IL-4)和白细胞介素-10(IL-10)水平,实时荧光PCR法检测肝脏组织铁调素基因(HAMP)和膜铁转运蛋白(Fpn)的mRNA表达。
结果
2
陈皮组和陈皮缺味方组在调节血红蛋白、血清铁、血清铁蛋白含量,改善脾指数,调节HAMP、Fpn mRNA及IL-1β、IFN-γ表达方面均呈现交互作用(均
P
<
0.05)。与模型组比较,陈皮组血红蛋白、血清铁含量及Fpn mRNA表达水平升高,铁蛋白含量、脾指数、HAMP mRNA及IL-1β、IL-6、TNF-α、IFN-γ水平降低(均
P
<
0.05);陈皮缺味方组血清铁含量、Fpn mRNA表达水平升高,脾指数、铁蛋白含量、HAMP mRNA及IL-1β、IFN-γ、IL-4水平降低(均
P
<
0.05)。
结论
2
陈皮对促炎症因子IL-6、TNF-α的抑制作用及对Fpn的上调作用可能在异功散全方改善慢性病贫血及铁代谢中发挥了关键作用。
Objective
2
To observe the role of dried tangerine peel in
Yigong
Powder improves iron metabolism and promotes red blood cell generation in anemia of chronic disease (ACD).
Methods
2
With a two-by-two factorial design
the
Yigong
Powder was divided into dried tangerine peel and
Chenpi
absent Decoction. According to the random number table method
32 zymosan-induced generalized inflammation (ZIGI) mice were randomly divided into the model group
the dried tangerine peel group
the
Chenpi
absent Decoction group
and the
Yigong
Powder group. The dried tangerine peel group
Chenpi
absent Decoction group and the
Yigong
Powder group were given dried tangerine peel(3.083 g/kg)
Chenpi
absent Decoction(12.33 g/kg)
and
Yigong
Powder(15.413 g/kg)by gavage to the corresponding group of mice. The model group was given an equal amount of physiological saline by gavage
and treated continuously for 7 days. After the completion of administration
the body weight of each group of mice was recorded. The hemoglobin
content of each group of mice was detected using a fully automatic cell counter
the serum iron content was detected using colorimetry
the serum ferritin content was detected using enzyme-linked immunosorbent assay (ELISA)
and the spleen index was calculated. The liver tissue inflammatory factors interleukin-1β (IL-1β)
interleukin-6 (IL-6)
tumor necrosis factor-α (TNF-α)
interferon-γ (IFN-γ)
interleukin-4 (IL-4)
and interleukin-10 (IL-10) levels were detected using Luminex method. The mRNA expressions of liver tissue hepcidin gene (HAMP) and membrane iron transporter (Fpn) were detected using real-time fluorescence PCR method.
Results
2
Dried tangerine peel and
Chenpi
absent Decoction both showed interactive effects in regulating hemoglobin
serum iron
serum ferritin content
improving spleen index
and regulating the mRNA expressions of HAMP
Fpn
as well as IL-1β and IFN-γ (
P
<
0.05). Compared with the model group
dried tangerine peel significantly increased hemoglobin
serum iron content
and Fpn mRNA expression in ZIGI model mice
while decreasing ferritin content
spleen index
HAMP mRNA expression
and the levels of IL-1β
IL-6
TNF-α
and IFN-γ (
P
<
0.05).
Chenpi
absent Decoction significantly increased serum iron content and Fpn mRNA expression in ZIGI model mice
while reducing spleen index
ferritin content
HAMP mRNA expression
and the levels of IL-1β and IFN-γ、IL-4 (
P
<
0.05).
Conclusion
2
The effects of dried tangerine peel on inflammatory factors (IL-6 and TNF-α) and Fpn may play a key role in the improvement effects of
Yigong
Powder on ACD and iron metabolism.
运脾法拆方研究异功散慢性病贫血铁代谢小鼠
activating spleen methodformula components analysisYigong Powderanemia of chronic diseaseiron metabolismmice
GANZ T. Anemia of inflammation[J]. N Engl J Med, 2019, 381(12): 1148-1157.
WEISS G, GOODNOUGH LT. Anemia of chronic disease[J]. N Engl J Med, 2005, 352(10):1011-1023.
LASOCKI S, MILLOT S, ANDRIEU V, et al. Phlebotomies or erythropoietin injections allow mobilization of iron stores in a mouse model mimicking intensive care anemia[J]. Crit Care Med, 2008, 36(8): 2388-2394.
罗梅宏.从“脾主运化”和“运脾生血”理论探讨慢性病贫血的中医病机和治疗[J]. 中医杂志,2013,54(18):1556-1557.
薛城,郑秦,季玉婷,等.异功散联合常规西药治疗慢性病贫血(脾气虚证)的随机、双盲、安慰剂对照临床研究[J]. 上海中医药杂志,2020,54(S1):81-85.
郑秦,管宇,王志成,等.异功散对脂多糖介导的小鼠铁代谢紊乱的影响[J]. 中医杂志,2015,56(20):1767-1770.
郑秦,姜一陵,季玉婷,等.异功散对小鼠慢性病贫血的治疗作用[J]. 实验动物与比较医学,2017,37(6):421-427.
ZHENG Q, GUAN Y, XIA LM, et al. Effect of yi Gong San Decoction on iron homeostasis in a mouse model of acute inflammation[J]. Evid Based Complementary Altern Med, 2016, 2016: 2696480.
姜一陵,郑秦,季玉婷,等.异功散调节巨噬细胞铁代谢的机制研究[J]. 上海中医药大学学报,2019,33(3):53-60.
季玉婷. 从抑制Toll样受体4信号通路介导的炎症反应探讨异功散治疗慢性病贫血的作用机制[D]. 上海:上海中医药大学,2020.
江育仁. 脾健不在补贵在运[J]. 上海中医药杂志,2002, 36(1): 4-7.
赵存义.古方方义与方名考释[M]. 2版.北京:中国中医药出版社,2012:177.
唐军.运脾法理论内涵及应用研究[D]. 沈阳:辽宁中医药大学,2018.
夏黎,罗梅宏. 异功散抗炎机制研究进展[J]. 山东中医杂志,2023, 42(8): 898-904.
ROY CN, ANDREWS NC. Anemia of inflammation: the hepcidin link[J]. Curr Opin Hematol, 2005, 12(2): 107-111.
THEURL I, AIGNER E, THEURL M, et al. Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications[J]. Blood, 2009, 113(21): 5277-5286.
NEMETH E, TUTTLE MS, POWELSON J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization[J]. Science, 2004, 306(5704):2090-2093.
DELGADO-VEGA AM, ALARCÓN-RIQUELME ME, KOZYREV SV. Genetic associations in type I interferon related pathways with autoimmunity[J]. Arthritis Res Ther, 2010, 12(Suppl 1): S2.
KANAMORI Y, MURAKAMI M, SUGIYAMA M, et al. Hepcidin and IL-1β[J]. Vitam Horm, 2019, 110: 143-156.
LUDWICZEK S, AIGNER E, THEURL I, et al. Cytokine-mediated regulation of iron transport in human monocytic cells[J]. Blood, 2003, 101(10): 4148-4154.
FERLA KL, REIMANN C, JELKMANN W, et al. Inhibition of erythropoietin gene expression signaling involves the transcription factors GATA-2 and NF-kappaB[J]. FASEB J, 2002, 16(13): 1811-1813.
JELKMANN W. Regulation of erythropoietin production[J]. J Physiol, 2011, 589(6): 1251-1258.
TANIGUCHI S, DAI CH, PRICE JO, et al. Interferon gamma downregulates stem cell factor and erythropoietin receptors but not insulin-like growth factor-I receptors in human erythroid colony-forming cells[J]. Blood, 1997, 90(6): 2244-2252.
LIBREGTS SF, GUTIÉRREZ L, DE BRUIN AM, et al. Chronic IFN-γ production in mice induces anemia by reducing erythrocyte life span and inhibiting erythropoiesis through an IRF-1/PU.1 axis[J]. Blood, 2011, 118(9):2578-2588.
OKONKO DO, MARLEY SB, ANKER SD, et al. Erythropoietin resistance contributes to anaemia in chronic heart failure and relates to aberrant JAK-STAT signal transduction[J]. Int J Cardiol. 2013, 164(3):359-364.
CANALI S, ZUMBRENNEN-BULLOUGH KB, CORE AB, et al. Endothelial cells produce bone morphogenetic protein 6 required for iron homeostasis in mice[J]. Blood, 2017, 129(4):405-414.
0
浏览量
8
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构